Virus injection takes on deadly brain tumor in new trial
NCT ID NCT07145047
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests whether injecting an oncolytic virus directly into brain tumors can treat recurrent glioblastoma, a fast-growing cancer. Twenty participants will receive up to six injections over several weeks, with regular checkups to monitor safety and tumor response. The goal is to find a tolerable dose and see if the virus can slow or shrink the cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- oncolytic virus
- What this could lead to
- If it works, this could point toward a new treatment option for recurrent glioblastoma, a brain cancer with few effective therapies.
- What could go wrong
- This is an early phase 1/2 trial with only 20 participants, so results may not apply broadly. The virus may cause side effects or fail to shrink tumors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA (GBM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mianyang Central Hospital
RECRUITINGMianyang, Sichuan, 621000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Custom-Made vaccine train the immune system to fight brain cancer?
- Can a virus injected into brain tumors fight recurrence?
- Can adding lenvatinib to standard care outsmart a tough brain cancer?
- Can a pill reach the brain and fight tumors?
- Targeted radiation delivered directly to brain tumor cavity in new trial
- Oxygen-Enhanced MRI could sharpen radiotherapy for deadly brain cancers